The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...
Brian Zanoni, MD, MPH, discusses forecasts that suggest declining global HIV rates but persistent gaps in care and funding.
4don MSNOpinion
HIV knows no borders, and the Trump administration's new strategy leaves Americans vulnerable, expert explains
Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...
Sichuan province has reported its first case of HIV-2 infection, marking a rare public health event in China. The finding, ...
4don MSNOpinion
HIV knows no borders, and the Trump administration’s new strategy leave Americans vulnerable – an HIV-prevention expert explains
The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About ...
In 2023, Campania recorded 228 new diagnoses of HIV infection, ranking fourth in Italy for the absolute number of cases, ...
News-Medical.Net on MSN
Investigating the impact of starting HIV drugs within days of infection
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...
Viral infections, including HIV and influenza, are associated with an increased risk of cardiovascular disease, including coronary heart disease and stroke.
Health minister says move to help nation achieve 2030 goal to end HIV as public health threat - Anadolu Ajansı ...
Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...
2don MSN
Early HIV drugs give immune system a brief reprieve before dysregulation returns, study finds
Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by starting HIV medication immediately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback